Eli Lilly's lower-priced insulin hits the market

Eli Lilly & Co.'s lower-priced authorized generic version of Humalog, an insulin injection, is now available for order in pharmacies, the drugmaker announced May 22.

The authorized generic, Insulin Lispro, will have a list price 50 percent lower than Humalog's current list price of about $275 per vial.

Insulin Lispro will sell for $137.35 for a single vial. A five-pack of the insulin pens will be $265.20.

Eli Lilly and other drug companies have come under increased pressure from lawmakers and the public to reduce the cost of prescription drugs in the U.S. Lawmakers have specifically targeted the skyrocketing price of insulin.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars